Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | hexamethonium bromide | 5938 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | hexamethonium bromide | 5938 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | ethambutol | 38081 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | ethambutol | 38081 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ethambutol | 38081 | drug-path |
Basal transcription factors | R-HSA-3232118 | map03022 | ethambutol | 38081 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | idoxuridine | 5905 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | idoxuridine | 5905 | drug-path |
Shigellosis | 0 | map05131 | amprolium | 16490 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | amprolium | 16490 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | amprolium | 16490 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | amprolium | 16490 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | amprolium | 16490 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | amprolium | 16490 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | amprolium | 16490 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | amprolium | 16490 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | amprolium | 16490 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | amprolium | 16490 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | prednisone | 5865 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | prednisone | 5865 | drug-path |